Real-world effectiveness and safety of oral semaglutide in people living with type 2 diabetes : A nationwide multicentre retrospective observational study (ENDO2 S-RWD)
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:26 |
|---|---|
| Enthalten in: |
Diabetes, obesity & metabolism - 26(2024), 4 vom: 01. März, Seite 1519-1523 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Moreno-Pérez, Oscar [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
53AXN4NNHX |
|---|
| Anmerkungen: |
Date Completed 05.03.2024 Date Revised 05.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1111/dom.15431 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366426133 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366426133 | ||
| 003 | DE-627 | ||
| 005 | 20240305232140.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1111/dom.15431 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1317.xml |
| 035 | |a (DE-627)NLM366426133 | ||
| 035 | |a (NLM)38151966 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Moreno-Pérez, Oscar |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Real-world effectiveness and safety of oral semaglutide in people living with type 2 diabetes |b A nationwide multicentre retrospective observational study (ENDO2 S-RWD) |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 05.03.2024 | ||
| 500 | |a Date Revised 05.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Multicenter Study | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a semaglutide |2 NLM | |
| 650 | 7 | |a 53AXN4NNHX |2 NLM | |
| 650 | 7 | |a Glucagon-Like Peptides |2 NLM | |
| 650 | 7 | |a 62340-29-8 |2 NLM | |
| 650 | 7 | |a Hypoglycemic Agents |2 NLM | |
| 700 | 1 | |a Reyes-Garcia, Rebeca |e verfasserin |4 aut | |
| 700 | 1 | |a Modrego-Pardo, Inés |e verfasserin |4 aut | |
| 700 | 1 | |a Doulatram-Gamgaram, Viyey Kishore |e verfasserin |4 aut | |
| 700 | 1 | |a Cases, Carlos Casado |e verfasserin |4 aut | |
| 700 | 1 | |a Guillen-Morote, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Mendoza, Nieves Arias |e verfasserin |4 aut | |
| 700 | 1 | |a Tejera-Pérez, Cristina |e verfasserin |4 aut | |
| 700 | 1 | |a Cárdenas-Salas, Jersy |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-Fuster, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Lardiés-Sánchez, Beatriz |e verfasserin |4 aut | |
| 700 | 1 | |a Márquez-Pardo, Rosa |e verfasserin |4 aut | |
| 700 | 1 | |a Pinés, Pedro |e verfasserin |4 aut | |
| 700 | 1 | |a Fernández-García, José Carlos |e verfasserin |4 aut | |
| 700 | 0 | |a SEEN Diabetes Area |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Diabetes, obesity & metabolism |d 1999 |g 26(2024), 4 vom: 01. März, Seite 1519-1523 |w (DE-627)NLM111220432 |x 1463-1326 |7 nnns |
| 773 | 1 | 8 | |g volume:26 |g year:2024 |g number:4 |g day:01 |g month:03 |g pages:1519-1523 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1111/dom.15431 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 26 |j 2024 |e 4 |b 01 |c 03 |h 1519-1523 | ||